Objective: To evaluate the long-term results of fat graft myringoplasty in adult and pediatric populations. Design: Prospective case series study. Main Outcome Measures: Patients witb chronic tympanic membrane perforations were considered candidates for fat graft myringoplasty. Excluded were patients witb purulent discharge, suspected ossicular disease, suspected cholesteatoma, or a perforation diameter greater than 6.5 mm. Fat was harvested from the ear lobule or subcutaneous tissue just posteriorinferior to tbe lobule. Results: Tbe study population comprised 27 adults and 11 children. Twenty-eight perforations were small (73.7%) and 10 were large (26.3%). Altogether, 31 of 38 perforations were successfully repaired (81.6%), including 22 of 28 small perforations (78.6%) and 9 of 10 large perforations (90%). Assessment by age showed that 23 of 27 perforations of the adults (85.2%) and 8 of 11 perforations of the children (72.7%) successfully closed (p = .648). Follow-up ranged from 25 to 53 months (mean 40.6 ± 8.3 months). No recurrence of the perforation during tbe follow-up period was recorded if the initial results were successful. The speech reception threshold improved significandy (18.5 ± 7.7 dB vs 23.5 ± 8 dB; p = .043). No significant sensorineural hearing loss occurred.Conclusions: Fat graft myringoplasty is a reliable technique for the closure of small-and medium-sized perforations. The grafting results showed excellent long-term durability. Given the simplicity of the technique, its short duration, and the favourable hearing results, fat graft myringoplasty should be considered tbe procedure of choice in patients with suitable perforations and when not otherwise contraindicated. SommaireObjectif: Evaluer les resultats a long terme de la myringoplastie avec greffe adipeuse dans des populations adulte et pediatrique. Devis: Serie de cas prospective. Methodes: Nous avons considere les patients avec une perforation tympanique chronique en excluant ceux avec une otorrhee purulente, une suspicion de pathologie ossiculaire ou d'un cholesteatome. Etaient aussi exclus les perforations de plus de 6.5 mm de diametre. Nous avons preleve le gras directement du lobule ou du tissu sous-cutane juste sous-jacent. Resultats: Nous avons etudie 27 adultes et 11 enfants. Vingt-buit perforations etaient petites et 10 grandes. Trente-et-une des 38 perforations ont ete reparees (81.6%), incluant 22 des 28 petites (78.6%) et 9 des 10 grandes. Pour ce qui est de I'age, 23 des 27 perforations chez les adultes (85.2%) et 8 des 11 chez les enfants ont ete fermees avec succes (p=.648). Nous n'avons note aucune recidive de perforation si la prise initiate etait un succes. Le seuil vocal s'est ameliore de iaqon significative (18.5±7.7 dB vs 23.5±8 dB ; p=.O43). Aucune perte de perception n'est a deplorer dans cette serie.Conclusion: La myringoplastie avec greffe adipeuse est une technique fiable pour la fermeture de petites et moyennes perforations. Les resultats montrent de plus une excellente performance a long terme. Etant donnes ...
In selected cases, AT can be a less invasive option in children with cholesteatoma limited to the attic and middle ear.
Vocal fold paresis in infants is difficult to diagnose. The risk for recurrent laryngeal nerve injury associated with TEF and TEF repair should be emphasized in these children. We recommend that all newborns with TEF should be examined by an otolaryngologist before operation to confirm the mobility of the vocal folds and to rule out other associated airway malformations, and examined after operation if respiratory difficulties develop.
The GFI is a reliable 4-item symptom index with excellent correlation to the presence of vocal cord lesions in children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.